Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVRI
3851
DELISTED
Everi Holdings
EVRI
| $246K | ﹤0.01% |
47,558
+17,481
| +58% | +$88.8K |
|
3852
Ocular Therapeutix
OCUL
$1.98B
| $246K | ﹤0.01% |
29,571
+15,542
| +111% | +$103K |
|
|
QTNT
3853
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $246K | ﹤0.01% |
832
+831
| +83,100% | +$239K |
|
|
LAND
3854
Gladstone Land Corp
LAND
$362M
| $245K | ﹤0.01% |
15,441
+4,283
| +38% | +$59.9K |
|
3855
Hawaiian Electric Industries
HE
$2.18B
| $244K | ﹤0.01% |
6,757
-75,420
| -92% | -$2.92M |
|
3856
CALL
MPLX
MPLX
$60.2B
| $244K | ﹤0.01% |
14,100
-40,900
| -74% | -$698K |
|
3857
Rogers Communications
RCI
$18.7B
| $244K | ﹤0.01% |
6,043
+712
| +13% | +$29.7K |
|
|
SHOE
3858
Shoe Station Group
SHOE
$428M
| $244K | ﹤0.01% |
16,718
+634
| +4% | +$7.58K |
|
|
SYRS
3859
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $244K | ﹤0.01% |
2,288
+1,139
| +99% | +$102K |
|
3860
CALL
3D Systems Corp
DDD
$620M
| $243K | ﹤0.01% |
34,800
-25,500
| -42% | -$191K |
|
3861
FB Financial Corp
FBK
$3.04B
| $243K | ﹤0.01% |
9,799
+4,133
| +73% | +$92.1K |
|
|
TGH
3862
DELISTED
Textainer Group Holdings limited
TGH
| $243K | ﹤0.01% |
29,843
+12,506
| +72% | +$102K |
|
3863
Invesco CurrencyShares Australian Dollar Trust
FXA
$97.9M
| $242K | ﹤0.01% |
3,519
-203
| -5% | -$13.3K |
|
|
AKTS
3864
DELISTED
Akoustis Technologies Inc
AKTS
| $242K | ﹤0.01% |
29,207
+17,009
| +139% | +$131K |
|
3865
PUT
Crown Holdings
CCK
$13.1B
| $241K | ﹤0.01% |
3,700
-19,600
| -84% | -$1.23M |
|
3866
CALL
Coherent
COHR
$75.6B
| $241K | ﹤0.01% |
5,114
-70,600
| -93% | -$2.8M |
|
3867
BRC Group Holdings
RILY
$291M
| $241K | ﹤0.01% |
11,078
+4,256
| +62% | +$81.6K |
|
|
BRY
3868
DELISTED
Berry Corp
BRY
| $240K | ﹤0.01% |
49,517
+28,592
| +137% | +$111K |
|
3869
Sierra Bancorp
BSRR
$527M
| $240K | ﹤0.01% |
12,694
+5,043
| +66% | +$90.9K |
|
|
HTBK
3870
DELISTED
Heritage Commerce
HTBK
| $240K | ﹤0.01% |
32,111
+13,929
| +77% | +$109K |
|
|
TSC
3871
DELISTED
TriState Capital Holdings, Inc.
TSC
| $240K | ﹤0.01% |
15,261
+6,355
| +71% | +$86.4K |
|
3872
Cato Corp
CATO
$66.5M
| $239K | ﹤0.01% |
29,234
+769
| +3% | +$7.58K |
|
3873
Franklin Covey
FC
$243M
| $239K | ﹤0.01% |
11,136
+2,432
| +28% | +$49.3K |
|
|
GDEN
3874
DELISTED
Golden Entertainment
GDEN
| $239K | ﹤0.01% |
26,811
+7,248
| +37% | +$67.4K |
|
3875
Stoke Therapeutics
STOK
$2.06B
| $239K | ﹤0.01% |
9,981
+3,783
| +61% | +$89.8K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.